» Authors » Juan Francisco Bulnes

Juan Francisco Bulnes

Explore the profile of Juan Francisco Bulnes including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 18
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Gonzalez-Urquijo M, Valdes F, Bulnes J, Torres-Alvarez J, Vargas J, Bergoeing M, et al.
Vascular . 2024 Dec; :17085381241307751. PMID: 39673086
Objective: To report a case series of three patients with symptomatic coronary-subclavian steal syndrome (CSSS) and to review the literature on published case series. Methods: We retrospectively reviewed three cases...
2.
Bulnes J, Gonzalez L, Velasquez L, Orellana M, Munoz Venturelli P, Martinez G
Front Cardiovasc Med . 2024 Jul; 11:1356023. PMID: 38993522
Acute Coronary Syndrome (ACS) significantly contributes to cardiovascular death worldwide. ACS may arise from the disruption of an atherosclerotic plaque, ultimately leading to acute ischemia and myocardial infarction. In the...
3.
Asenjo-Lobos C, Gonzalez L, Bulnes J, Roque M, Munoz Venturelli P, Rodriguez G
Clin Res Cardiol . 2023 Aug; 113(2):246-259. PMID: 37650912
Background: Chronic inflammation is considered a risk factor for the development of atherosclerosis and cardiovascular (CV) events. We seek to assess the risk of CV events in patients with Systemic...
4.
Martinez G, Fuensalida A, Sepulveda P, Bulnes J, Quitral J, Pacheco F, et al.
Rev Med Chil . 2023 Jun; 150(11):1422-1430. PMID: 37358167
Background: Transcatheter aortic-valve implantation (TAVI) was introduced in 2002 and the first implants in our country were performed in 2010. Aim: To review the TAVI experience in our hospital, considering...
5.
Gonzalez L, Bulnes J, Orellana M, Munoz Venturelli P, Rodriguez G
Pharmaceutics . 2022 Jul; 14(7). PMID: 35890291
Inflammation is a key feature of atherosclerosis. The inflammatory process is involved in all stages of disease progression, from the early formation of plaque to its instability and disruption, leading...
6.
Sanfuentes B, Bulnes J
Medwave . 2018 Nov; 18(7):e7332. PMID: 30451816
Introduction: There are several effective therapeutic alternatives for stable coronary artery, in terms of prevention of cardiovascular morbidity and mortality. However, the best way to achieve symptomatic control is a...